We present an extension of the perfusion microplate technology and incorporate it into a microfluidic platform for passive pump-free perfusion cell culture and cell-based assays. By incorporating the perfusion microplate technology into microfluidic devices, all the benefits of microfluidic technologies, such as small sample volumes, fast and efficient fluidics exchanges and fluid properties at the micro-scale, can be fully taken advantage of with this passive pump-free perfusion-based microfluidic platform.
INTRODUCTION
Currently, most of the perfusion-based cell culture systems for mimicking in vivo-like cell environment were based on microfluidic devices and media were perfused by external pumps [1] [2] [3] [4] . Also, these devices typically require a long period of hands-on learning because of external pumping accessories required for fluid pumping until they can be used effectively. Therefore, it is advantageous to develop a pump-free perfusion-based cell culture system or/and method that will require little to no hands-on learning but yet is effective in providing an in vivo-like cell environment for improving cellular morphology, cell viability, lifespan and cell-specific functionality. In this study, we extend and incorporate the perfusion microplate technology into a microfluidic platform for passive pump-free perfusion cell culture and cell-based assays.
EXPERIMENTAL
Based on the perfusion microplate technology [5] , which utilizes a combination of hydrostatic pressure generated by different liquid levels in the wells and fluid wicking through narrow strips of a porous membrane connecting the wells to generate fluid flow, a series of pump-free membrane-controlled perfusion microfluidic devices was developed. Each pump-free membrane-controlled perfusion microfluidic device comprises at least three basic components: an open well, a micron-sized deep chamber/channel and a wettable porous membrane (Fig. 1) . Each component is fluidly connected either by the porous membrane or by the micron-sized deep chamber/channel. 
RESULTS AND DISCUSSION
In addition to introducing continuous perfusion flow ( Fig. 2) , continuous side-by-side fluid flow could be introduced to generate spatially and temporally stable concentration gradient (Fig. 3 ), and to "pattern" and culture cells in the micron-sized deep cell culture channel such that only half of the channel would be seeded and cultured with cells ( Fig. 4 and 5 ). We combined this side-by-side cell seeding with the concentration gradient generation and used them to perform an end-point cell migration assay using MDA- MB-231 cells. We first seeded MDA-MB-231 cells into half of the micron-sized deep cell culture channel and after cell attachment, we generated an EGF concentration gradient across the cell culture channel width. After 16 hours of culture in serum-free medium, there were very few cells (approximately 25 cells) migrated towards the other half of the cell culture channel when only media were perfused into the cell culture channel (Fig. 6 ). On the other hand, when EFG and medium were perfused side-by-side into the cell culture channel generating an EGF concentration gradient, more MDA-MB-231 cells (approximately 65 cells) migrated towards the other half of the cell culture channel where the EGF concentration was higher. The experiments demonstrated the feasibility of performing an end-point migration assay using the pump-free membrane-controlled perfusion microfluidic device. 
CONCLUSION
Based on the perfusion microplate technology, we developed a pump-free membrane-controlled perfusion microfluidic platform and demonstrated their use for pump-free perfusion cell culture and cell-based assays. By incorporating the perfusion microplate technology into microfluidic devices, all the benefits of microfluidic technologies can be fully taken advantage of with this perfusion-based microfluidic platform.
